-
Trial Okayed in Germany for Covid-19 Vaccine
Regulators in Germany cleared a clinical trial to begin testing a vaccine with synthetic RNA to prevent coronaviruses from causing Covid-19 infections.
-
BARDA Chief Removed for “Politics and Cronyism”
The director of the federal agency protecting against pandemics says he was removed for refusing to endorse President Trump’s preferred Covid-19 treatment.
-
Covid-19 Real-World Evidence System Created
Two health care data science companies are offering a system for assessing proposed treatments from health records data on patients with Covid-19 infections.
-
Study Probes Lupus Digital Diagnostics
A company creating diagnostics for autoimmune disorders is beginning a study next month to measure links between its blood-based and digital indicators for lupus.
-
FDA Clears Home Covid-19 Diagnostic Test
The Food and Drug Administration today granted an emergency authorization for a Covid-19 diagnostic test performed at home and sent back to a lab.
-
Digital Health Research Platform Set for Covid-19
A group of medical technology companies are forming a research platform and registry for clinical trials of Covid-19 treatments among home-bound participants.
-
Fast, Simple Covid-19 Antibody Test Being Developed
An engineering lab is creating an easy-to-use test of immune-system antibodies to the SARS-Cov-2 virus responsible for Covid-19 infections.
-
Infographic – Biotech Remains Hottest Venture Sector
A report on venture capital investments for the first quarter of 2020 shows biotechnology companies remain the largest recipients of venture investor dollars.
-
Venture Deals Decline in Q1, Biotech Sizzles Again
The number of venture deals declined for the third straight quarter as 2020 opened, but biotechnology remained the hottest single sector for investors.
-
Moderna Gains $483M for Covid-19 Vaccine
A government preparedness agency awarded biotechnology company Moderna Inc. $483 million to advance its Covid-19 vaccine through clinical trials.